World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
25163
World Ranking
19944
National Ranking
801

Overview

William Arcese is affiliated with Sapienza University of Rome in Italy and has an extensive publication record primarily in the field of Medicine. Their research predominantly focuses on hematology and related subfields such as oncology, genetics, public health, and epidemiology.

The scientist's main areas of study include:

  • Hematology
  • Public Health, Environmental and Occupational Health
  • Oncology
  • Genetics
  • Epidemiology

Key topics covered in William Arcese's research comprise:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

William Arcese has contributed to several notable scientific papers. Recent publications include:

  • Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia, 2020, Haematologica
  • Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation, 2021, Bone Marrow Transplantation
  • Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters, 2020, British Journal of Haematology
  • Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO), 2020, Frontiers in Oncology
  • Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation, 2023, The Journal of Infectious Diseases

Their frequent co-authors include:

  • Didier Blaise
  • Mohamad Mohty
  • Maria Teresa Voso
  • Fabio Ciceri
  • Myriam Labopin

Regarding publication venues, William Arcese has contributed multiple articles to the following journals:

  • Blood
  • Bone Marrow Transplantation
  • Transplantation and Cellular Therapy
  • Haematologica
  • Cancer Medicine

Best Publications

  • OUTCOME OF CORD-BLOOD TRANSPLANTATION FROM RELATED AND UNRELATED DONORS

    Eliane Gluckman;Vanderson Rocha;Agnes Boyer-Chammard;Franco Locatelli

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

    Vanderson Rocha;Jacqueline Cornish;Eric L. Sievers;Alexandra Filipovich

  • Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

    A. Gratwohl;J. Hermans;J. Goldman;W. Arcese

  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

    Mary Eapen;Vanderson Rocha;Guillermo Sanz;Andromachi Scaradavou

  • Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

    Enric Carreras;Hartmut Bertz;William Arcese;Jean-Paul Vernant

  • Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

    Eliane Gluckman;Vanderson Rocha;William Arcese;Gérard Michel

  • Allogeneic Stem Cell Transplantation for Agnogenic Myeloid Metaplasia: A European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study

    P. Guardiola;J. Anderson;G. Bandini;F. Cervantes

  • Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia

    Franco Locatelli;Vanderson Rocha;Claude Chastang;William Arcese

  • Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients

    A. Bacigalupo;B. Bruno;P. Saracco;E. Di Bona

  • Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia

    Francesco Buccisano;Luca Maurillo;Maria Ilaria Del Principe;Giovanni Del Poeta

  • Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

    A Bacigalupo;G Broccia;G Corda;W Arcese

  • Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone : a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation

    M T Van Lint;C Uderzo;A Locasciulli;I Majolino

  • Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy

    Mary Eapen;John P. Klein;John P. Klein;Annalisa Ruggeri;Stephen Spellman

  • Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.

    J. F. Apperley;F. R. Mauro;J. M. Goldman;W. Gregory

  • Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia

    F. Lo Coco;D. Diverio;G. Avvisati;W. Arcese

  • Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

    Paolo Di Bartolomeo;Stella Santarone;Gottardo De Angelis;Alessandra Picardi

  • Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors : a study on behalf of the European Group for Blood and Marrow Transplantation

    Ph. Guardiola;R. Pasquini;I. Dokal;J. J. Ortega

  • Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Olle Ringdén;Myriam Labopin;Norbert Claude Gorin;Katarina Le Blanc

  • Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.

    A Gratwohl;J Hermans;J Apperley;W Arcese

Frequent Co-Authors

Franco Mandelli
Franco Mandelli Sapienza University of Rome
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo
Eliane Gluckman
Eliane Gluckman Université Paris Cité
Sergio Amadori
Sergio Amadori University of Rome Tor Vergata
Myriam Labopin
Myriam Labopin Université Paris Cité
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Arnon Nagler
Arnon Nagler Sheba Medical Center
Andrea Bacigalupo
Andrea Bacigalupo Catholic University of the Sacred Heart
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine often involves extensive education and hands-on training, but online learning is transforming these pathways. Many healthcare professionals are now advancing their education through flexible and accelerated online programs.

For registered nurses looking to enhance their credentials, online rn-bsn programs without clinicals provide a fast and convenient route to a bachelor’s degree, eliminating the need for additional in-person practice. If you’re interested in doctoral-level nursing, some of the dnp programs offer more accessible entry requirements and coursework flexibility.

Time is a critical factor for many aspiring healthcare professionals. Those seeking a swift transition to advanced practice roles may consider enrolling in the shortest post master's dnp program, designed to minimize completion time without sacrificing rigor. Similarly, individuals starting their nursing journey can benefit from a 9 month lpn program available online, allowing for quick entry into the workforce.

By exploring these online degree options, students can find flexible and efficient routes to advance their medical careers while balancing work and personal commitments.

Best Scientists Citing William Arcese

Trending Scientists

Recently Published Articles